Expression data from publicly available databases (TCGA RNA-seq, n = 667; CGGA RNA-seq, n = 693; CGGA microarray, n = 301; and GSE16011, n = 284) were further used to evaluate the expression levels of TREM1 mRNA in glioma of different WHO grades. This evidence concerns the gene TREM1 and central nervous system cancer.